Heart Failure: A Companion to Braunwald's Heart Disease

Acute Heart Failure

Nearly one third of acute heart failure (AHF) patients die or are rehospitalized within 90 days after discharge in the United States, with similar numbers in Europe. Despite a decade of intensive research efforts, substantially improving outcomes remains an elusive…

Disease Prevention in Heart Failure

Prevention of heart failure is an urgent public health need with national and global implications. Despite recent advances in the therapy of cardiovascular disorders, heart failure remains a challenging disease with a high prevalence ( Fig. 35.1 ) and a…

Hemodynamics in Heart Failure

The first right heart catheterization (RHC) in humans was performed in 1929 by Dr. Werner Forssmann (on himself), who ultimately shared in the 1956 Nobel Prize in Medicine with Andre Cournard and Dickinson Richards for their work in cardiac catheterization.…

Biomarkers and Precision Medicine in Heart Failure

Acknowledgments Dr. Ibrahim is supported in part by the Dennis and Marilyn Barry Fellowship in Cardiology Research. Dr. Gaggin is supported in part by the Ruth and James Clark Fund for Cardiac Research Innovation. Dr. Januzzi is supported in part…

Cardiac Imaging in Heart Failure

Definition of Heart Failure Heart failure can be defined as a clinical syndrome caused by an abnormality of cardiac structure or function that results in failure to deliver oxygen at a rate commensurate with the needs of the body tissues…

Clinical Evaluation of Heart Failure

Introduction and Goals of Clinical Evaluation Optimal implementation of heart failure therapy requires expeditious and accurate diagnosis as well as determination of the severity of the disease and, wherever possible, identification of its cause. The earlier in the clinical course…